FGL Reference

Plain English

What it is

FGL is a lab-made peptide, which is a short chain of the building blocks that make up proteins. It copies a small piece of a natural brain molecule called NCAM (neural cell adhesion molecule) that helps brain cells link up and talk to each other. It is sold as a research chemical, not as an approved medicine.

What people use it for

In nootropic (brain-boosting) circles, people bring it up for brain rewiring, stroke recovery, and repairing thinking ability. Actual real-world use of it is rare.

What the science shows

The published work so far is in lab dishes and animals, where FGL stirred up brain stem cells and improved the way brain circuits adapt and strengthen. There is no human evidence that it improves memory, recovery, or brain repair.

The catch

FGL is not approved by the FDA for any use. The brain-growth and cognition claims come from cell and animal studies only and have not been shown to work in people.

Reference summary

Animal and cell studies describe NCAM / FGFR-1-related neuroplasticity, neural stem-cell mobilization, and dentate-gyrus plasticity. Human outcome data are absent.

Regulatory and posture

Categories

Cognitive, Recovery

Aliases

FG Loop peptide, NCAM mimetic peptide, Neural cell adhesion molecule-derived peptide

Evidence posture

preclinical - Preclinical NCAM mimetic. Community neurogenesis and cognition claims are not human-validated.

Regulatory status

No FDA-approved FGL drug label. Published evidence is preclinical; FGL is not an approved stroke, neurogenesis, cognitive-enhancement, or neurorepair treatment.

Content review status

research reference

Related tools

• Protocol builder overview - Public overview of the Pro protocol builder.